AVEO Oncology Reports First Quarter 2021 Financial Results and Provides Business Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Published: May 05, 2021
Company reports first quarter total revenue of $12.0 million
First quarter 2021 XHANCE net revenue of $11.0 million increased 55% compared to first quarter 2020
Conference call and webcast to be held today at 8:00 a.m. Eastern Time
YARDLEY, Pa., May 05, 2021 (GLOBE NEWSWIRE) OptiNose AS (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported financial results for the quarter ended March 31, 2021, and provided operational updates.
“XHANCE net revenues increased 55% in the first quarter of 2021 compared to first quarter 2020,” stated CEO Peter Miller. “We believe this is strong growth, particularly in the context of the continuing impact of the COVID-19 pandemic on the number of patients visiting physician offices and pandemic-related restrictions that continue to limit in-person detailing of physician offices by our territory managers. Improvement to the busines
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Lee Enterprises Provides Update On Digital Transformation Strategy and Growth Targets
Lee Enterprises Inc.April 5, 2021 GMT
Three-Pillar Strategy Focused on Growing Base of Annualized Recurring Revenue and Driving Shareholder Value
Also Announces Stock Exchange Listing Transfer to Nasdaq
Company to Host Conference Call at 9:00 a.m. CT Today
DAVENPORT, Iowa , April 05, 2021 (GLOBE NEWSWIRE) Lee Enterprises, Incorporated (NYSE: LEE), a major subscription and advertising platform and a leading provider of high quality, trusted, local news and information in 77 markets, today provided an update on its digital transformation and growth strategy.
Zai Lab Announces Financial Results for Second-half and Full-year 2020
March 01, 2021 07:00 ET | Source: Zai Lab Limited Zai Lab Limited Company to Host Conference Call and Webcast Today at 8:00 a.m. ET
SHANGHAI and SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today reported financial results for the second half and full year of 2020, along with corporate updates.
“2020 was another year of great accomplishment for Zai Lab,” said Dr. Samantha Du, Founder, Chairperson and Chief Executive Officer of Zai Lab. “We successfully launched ZEJULA for both second-line and first-line ovarian cancer and Optune for glioblastoma in China. We submitted NDAs and were granted priority reviews by China’s National Medical Products Administration (NMPA) for both QINLOCK for advanced gastrointestinal stromal tumors (GIST) and NUZYRA for community-acquire
Optinose Announces Reporting Date for Fourth Quarter 2020 Financial Results globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.